Target intelligence / Profile preview

ARF like GTPase 2 binding protein pseudogene 2 (ARL2BPP2)

Target: ARL2BPP2
Molecular classification: Other — specifically, "Pseudogene"

Overview

ARF like GTPase 2 binding protein pseudogene 2 (ARL2BPP2) is a human pseudogene with no known protein product and no established biological function or disease association. It is often confused with ARL2BP, a functional protein-coding gene involved in photoreceptor function and linked to disorders such as retinitis pigmentosa. ARL2BPP2 is not considered a therapeutic or molecular target and does not interact with drugs or play a role in disease biology.

Other names: ARL2BPLbcm1040ADP-ribosylation factor-like 2 binding protein pseudogene 2ADP-ribosylation factor like 2 binding protein-likelyADP ribosylation factor-like 2 binding protein pseudogene 2

Beyond the preview

Go deeper on ARF like GTPase 2 binding protein pseudogene 2 (ARL2BPP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ARF like GTPase 2 binding protein pseudogene 2 (ARL2BPP2).

Explore the full profile